Related Experiment Video
Updated: Aug 2, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Parkinson's and Alzheimer's: new tools, new attitudes in patient care
L R Jenkyn1, D J Coffey, A G Reeves
1Section of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Abstract:
In 1946, the differential diagnosis of cognitive failure resided in the hands of psychiatrists. Not until the late 1960s was permanent doubt cast on the arteriosclerotic origins of dementia. Neuro-diagnostic studies 50 years ago were limited to skull x-rays. Many neurologic signs that would now be considered indicative of Parkinson's disease (PD) were thought in 1946 to typify old age. The diagnosis of PD was made on clinical grounds, and in that regard little has changed. For treatment of PD, textbooks then had little to offer, compared with the wide range of drug therapies available today. Unknown in the mid-1940s, the molecular biology of DNA now allows practitioners a glimpse at the highly complex and multifactorial origins of Alzheimer's disease.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual.
Parkinson Disease l: Introduction